STOCK TITAN
  1. Home
  2. Sec-filings
  3. LMED
  4. [8-K] LataMed AI Corp. Reports Material Event

LATAMED AI Corp. (LMED) boosts authorized shares and enacts 5-for-1 stock split

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

LATAMED AI Corp. amended its Nevada charter to significantly expand its capital structure and split its stock. Authorized common stock increased from 700,000,000 shares to 3,500,000,000 shares, par value $0.0001 per share, and authorized preferred stock increased from 300,000,000 shares to 1,500,000,000 shares, par value $0.0001 per share. The change also effected a five-for-one forward split of issued and outstanding common shares, reclassifying each one share into five shares of common stock.

Positive

  • None.

Negative

  • None.

Insights

LATAMED AI Corp. expanded authorized shares and executed a 5:1 forward split.

LATAMED AI Corp. increased authorized common stock from 700,000,000 to 3,500,000,000 shares and preferred stock from 300,000,000 to 1,500,000,000, each with par value $0.0001 per share. This provides more capacity for future equity issuance across both common and preferred classes.

The company also implemented a 5:1 forward split of issued and outstanding common shares, so each existing share became five shares. While the split changes share count and per-share price mechanics, it does not, by itself, alter total shareholder equity.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Authorized common stock before change 700,000,000 shares Authorized common stock prior to Certificate of Change under NRS 78.209
Authorized common stock after change 3,500,000,000 shares Authorized common stock following Nevada Certificate of Change
Authorized preferred stock before change 300,000,000 shares Authorized preferred stock prior to Certificate of Change
Authorized preferred stock after change 1,500,000,000 shares Authorized preferred stock following Nevada Certificate of Change
Par value per share $0.0001 per share Par value for both common and preferred stock
Forward split ratio 5-for-1 Each one issued and outstanding common share reclassified into five shares
Filing number 20265873101 Nevada Secretary of State filing number for Certificate of Change
Certificate filing date July 2, 2026 Date Certificate of Change was filed in Nevada
Certificate of Change Pursuant to NRS 78.209 regulatory
"filed a Certificate of Change Pursuant to NRS 78.209 with the Secretary of State"
authorized common stock financial
"the Company’s authorized common stock increased from 700,000,000 shares to 3,500,000,000 shares"
authorized preferred stock financial
"its authorized preferred stock increased from 300,000,000 shares to 1,500,000,000 shares"
par value financial
"par value $0.0001 per share, and its authorized preferred stock increased"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
five-for-one (5:1) forward split financial
"the Certificate of Change effected a five-for-one (5:1) forward split"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What capital changes did LATAMED AI Corp. (LMED) disclose in this 8-K?
LATAMED AI Corp. expanded its authorized share capital and executed a stock split. Authorized common stock rose to 3,500,000,000 shares and preferred stock to 1,500,000,000 shares, both at $0.0001 par value, and the company implemented a five-for-one forward split of outstanding common shares.

How many common shares is LATAMED AI Corp. (LMED) now authorized to issue?
The company is now authorized to issue 3,500,000,000 common shares. This is an increase from 700,000,000 authorized common shares, with each share having a par value of $0.0001, as reflected in the Certificate of Change filed in Nevada.

What happened to LATAMED AI Corp. (LMED) preferred stock authorization?
Authorized preferred stock increased to 1,500,000,000 shares. Previously 300,000,000, the preferred share authorization was expanded while maintaining a par value of $0.0001 per share under the Nevada Certificate of Change filed on July 2, 2026.

What is the ratio of LATAMED AI Corp. (LMED) forward stock split?
The company effected a five-for-one forward stock split. Each one issued and outstanding share of common stock was reclassified into five shares of common stock, increasing the number of shares outstanding without changing aggregate shareholder ownership.

When did LATAMED AI Corp. (LMED) file the Certificate of Change for these actions?
The Certificate of Change was filed on July 2, 2026. LATAMED AI Corp., a Nevada corporation, filed it with the Nevada Secretary of State under Filing No. 20265873101 to implement the capital increases and forward split.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 2, 2026

 

LATAMED AI CORP.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-52543

 

26-3670551

(State or other jurisdiction

of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

Av. Rómulo Gallegos con Av. Las Palmas

Edif. Torre Gerencial Los Andes

Caracas 1071, Venezuela

(Address of principal executive offices, including zip code.)

 

+1 787 476 2350

(Telephone number, including area code)

 

Catalyst Crew Technologies Corp.

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On July 2, 2026, LataMed AI Corp., a Nevada corporation (the “Company”), filed a Certificate of Change Pursuant to NRS 78.209 (the “Certificate of Change”) with the Secretary of State of the State of Nevada (Filing No. 20265873101), reflecting the foregoing proportional increases in authorized capital stock. As set forth in the Certificate of Change, the Company’s authorized common stock increased from 700,000,000 shares to 3,500,000,000 shares, par value $0.0001 per share, and its authorized preferred stock increased from 300,000,000 shares to 1,500,000,000 shares, par value $0.0001 per share.

 

In connection with the increase in authorized capital stock described above, the Certificate of Change effected a five-for-one (5:1) forward split of the Company’s issued and outstanding shares of Common Stock (the “Forward Split”), pursuant to which each one (1) issued and outstanding share of Common Stock was reclassified into five (5) shares of Common Stock.

 

A copy of the Certificate of Change is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

 

Description

3.1

 

Certificate of Change Pursuant to NRS 78.209, filed with the Secretary of State of the State of Nevada on July 2, 2026

104 

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

LATAMED AI CORP.

 

 

 

 

Dated: July 10, 2026

By:

/s/ Kevin Rodan Levy

 

 

Kevin Rodan Levy

 

 

 

Chief Executive Officer

 

 

 
3

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

6 documents

Other Documents